MétaCan
Menu
Back to cohort
Record W2147324688 · doi:10.1016/j.bbmt.2003.12.177

Canadian pilot trial of haplo-identical donor transplantation

2004· article· en· W2147324688 on OpenAlexaffabout
I. Walker, Guy Cantin, Félix Couture, Nathalie Dhédin, Rebecca Barty, Ronan Foley, Robert Sutherland, Kirk R. Schultz

Bibliographic record

VenueBiology of Blood and Marrow Transplantation · 2004
Typearticle
Languageen
FieldMedicine
TopicHematopoietic Stem Cell Transplantation
Canadian institutionsUniversity of British ColumbiaUniversité de MontréalUniversité LavalUniversity of TorontoMcMaster UniversityCanadian Blood Services
Fundersnot available
KeywordsMedicineThymoglobulinMelphalanRegimenSurgeryChemotherapyGastroenterologyThioTEPAInternal medicineTransplantationUrologyCyclophosphamideKidney transplantation

Abstract

fetched live from OpenAlex

Background: CBMTG multi-centre pilot study of haplo-identical donor BMT. AIMS: To assess 1. Ability to collect suitable graft (CD34+ ≥ 5 x 106/kg and CD3 <1 x 105/kg recipient body weight), 2. Toxicity, 3. Survival to day +100. Eligibility: All diagnoses and ages; accrual to end after 20 patients with AML in remission and age less than 55 years. Methods: Modified Perugia regimen, chemotherapy alone; melphalan 140 mg/m2 d -9, thiotepa 10 mg/kg day -7, fludarabine 40 mg/m2days -7 to -3, and ATG (Thymoglobulin, Sangstat) days -6 to -2 (total 10.5 mg/kg). Ganciclovir (GC) 5 mg/kg days 5–20 then x5/week until day +100 then x3/week until 210 (subjects 1–3), foscarnet (FC)90 mg/kg days 4–21 then short course pre-emptive GC or FC (subjects 4–11); fluconazole; cotrimoxazole. G-CSF 16 μg/kg daily x 5 until second pheresis day. CliniMACS (MiltenyiBiotec). RESULTS: Eleven (11) patients with AML have been transplanted from 4 centres, 8 female, 3 male, mean age 39 (range 19–60). Disease status, first CR 1/11, second CR 4/11, third CR1/11, relapse 5/11. Graft CD34+ ≥ 5 x 106/kg was achieved in all cases, median 13.72 x 106/kg (Q1, Q3: 8.92, 16.61; min 5.59, max 22.2), and CD3+ was <1 x 105/kg in all cases, median of 0.49 x104/kg (Q1, Q3: 0.33, 1.64; min 0.22, max 4.10). Ten (10) of the 11 patients have died, median survival 109 days (Q1, Q3: 67, 153; min 0, max > 841). Survival to day +100 6/11 (55%). Four (4) patients died of leukemic relapse, 6 of infection. Of 6 patients dying of infection, CMV was a definite cause in 4. Of 4 dying with relapse, CMV was significant in 1 and asymptomatic in another. Engraftment was assessed in 10 patients who survived >0 days. Granulocyte engraftment (>0.5 x 109/L) achieved in all patients, median 12 days (Q1, Q3: 11, 16; min 8, max 70). Platelet engraftment (>20 x 109/L) achieved in 8 of 10 patients, median of 18 days (Q1, Q3: 14, 37; min 9, max 97). The two platelet non-engrafters died on days + 45 and +61. Toxicity was low, with one toxic death (day 0), and the Bearman organ toxicity gradings were < grade 2 in all other patients. Conclusions: Haplo-identical transplantation is feasible, with a high engraftment rate, minimal toxicity and minimal risk of graft versus host disease and rejection. However, relapse and CMV infection were frequent complications in this ultra-high risk group of patients. Physicians have been reluctant to refer earlier.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.220
Threshold uncertainty score0.438

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.001
Science and technology studies0.0010.001
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.258
Teacher spread0.241 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2004
Admission routes2
Has abstractyes

Explore more

Same venueBiology of Blood and Marrow TransplantationSame topicHematopoietic Stem Cell TransplantationFrench-language works237,207